688091 Stock Overview
Shanghai Yizhong Pharmaceutical Co., Ltd.
Shanghai Yizhong Pharmaceutical Co., Ltd. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||CN¥58.25|
|52 Week High||CN¥96.18|
|52 Week Low||CN¥55.24|
|1 Month Change||-3.53%|
|3 Month Change||-18.02%|
|1 Year Change||-1.37%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||77.88%|
Recent News & Updates
|688091||CN Pharmaceuticals||CN Market|
Return vs Industry: 688091 underperformed the CN Pharmaceuticals industry which returned 6.6% over the past year.
Return vs Market: 688091 exceeded the CN Market which returned -5.6% over the past year.
|688091 Average Weekly Movement||5.3%|
|Pharmaceuticals Industry Average Movement||4.3%|
|Market Average Movement||4.7%|
|10% most volatile stocks in CN Market||8.1%|
|10% least volatile stocks in CN Market||2.9%|
Stable Share Price: 688091 is not significantly more volatile than the rest of CN stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: 688091's weekly volatility (5%) has been stable over the past year.
About the Company
Shanghai Yizhong Pharmaceutical Co., Ltd. engages in the development of anti-tumor drugs and related products in China. It develops a dosage form of paclitaxel, an anti-tumor chemotherapeutic. Shanghai Yizhong Pharmaceutical Co., Ltd.
Shanghai Yizhong Pharmaceutical Co., Ltd. Fundamentals Summary
|688091 fundamental statistics|
Is 688091 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|688091 income statement (TTM)|
|Cost of Revenue||CN¥25.31m|
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
|Earnings per share (EPS)||1.18|
|Net Profit Margin||51.02%|
How did 688091 perform over the long term?See historical performance and comparison